Navigating Brazil & Mexico's Hemodialysis Market: A Pure Global Guide to ANVISA and COFEPRIS for MedTech Innovators in LATAM episode artwork

EPISODE · Sep 27, 2025 · 2 MIN

Navigating Brazil & Mexico's Hemodialysis Market: A Pure Global Guide to ANVISA and COFEPRIS for MedTech Innovators in LATAM

from LATAM MedTech Insights

In this episode of LATAM MedTech Insights, we explore the rapidly growing but complex market for hemodialysis machines and dialyzers in Latin America. We uncover the key drivers behind the region's multi-billion dollar renal care industry, focusing on the specific regulatory, logistical, and commercial hurdles in key countries like Brazil, Mexico, and Colombia. We examine real-world scenarios where manufacturers have faced significant delays and strategic pivots. For example, a European dialyzer company with full CE marking was stalled for over a year trying to enter Brazil, simply because they were unprepared for the mandatory in-person ANVISA inspection of their overseas facility. This single oversight cost them millions in potential revenue and market share. We break down why such situations are common and how they can be avoided. Key Takeaways: - Are you prepared for the unique Brazilian GMP certification process required by ANVISA before your product can be sold? - How does your market entry strategy for Mexico account for COFEPRIS's specific dossier and labeling requirements? - What are the key differences in reimbursement models between Colombia and Argentina that could impact your sales strategy? - How can you build a resilient supply chain to handle customs and distribution challenges across diverse LATAM territories? - Is partnering with local dialysis clinics a better strategy than direct sales for your technology? - What are the post-market surveillance requirements you must maintain to ensure long-term compliance in the region? - How can you leverage your existing registrations to fast-track entry into smaller but growing markets like Peru and Chile? Navigating the complexities of the Latin American MedTech market is a challenge. At Pure Global, we offer end-to-end regulatory consulting solutions, combining local expertise with advanced AI to streamline global market access. We act as your local representative and registration holder, managing everything from initial strategy to post-market surveillance. Contact us to accelerate your growth in Latin America at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published Sep 27, 2025

Embed this episode

Ready to play

Navigating Brazil & Mexico's Hemodialysis Market: A Pure Global Guide to ANVISA and COFEPRIS for MedTech Innovators in LATAM

0:00 2:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of LATAM MedTech Insights?

This episode is 2 minutes long.

When was this LATAM MedTech Insights episode published?

This episode was published on September 27, 2025.

Can I download this LATAM MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!